
\chapter*{Misc}

A specific chromosomal translocation in 
chronic myeloid leukemia (CML) 
results in a constitutively active tyrosine-kinase (BCR-ABL)
that can be targeted with tyrosine kinase inhibitors such as imatinib~%
\autocite{drukerEfficacy2001}.


